http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2665419-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a0c3e4b714908382e152c4ee0b8ed0b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
filingDate 2009-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f27b440607af5b8ac6699d34ac67d37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_918c66f383468ac10742d2eff51f5706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5f1ec95339a515cdebbb5484d441f0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_982b55a24cee14c33e5b7c9e05a11f09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b97238619b1337be100c8cebe6e0924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b21c3f86e595d486e76c784672f23c54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c7b363a1bc7df13e9260314fb11f13d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a77f7c555b9e24809cda7e57a33c8676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff44e9f4ade0f9f06f15f500f8826f1
publicationDate 2018-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2665419-T3
titleOfInvention 1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
abstract A compound of Formula I: ** (See formula) ** or a pharmaceutically acceptable salt thereof, in combination with an anti-PD-1 antibody for use in the treatment of a cancer; wherein R1 is NH2 or CH3; R2 is Cl, Br, CF3, CH3 or CN; R3 is H or F; and n is 1 or 2.
priorityDate 2008-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10290740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457313472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411318242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454397067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456636445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452931781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86653488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21866502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136623549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415973086

Total number of triples: 77.